Signaturefd, LLC Adaptimmune Therapeutics PLC Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Signaturefd, LLC holds 6,620 shares of ADAP stock, worth $4,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,620

Holding current value

$4,369

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$0.92 - $1.39 $6,090 - $9,201	6,620 New	6,620 $6,000
Q1 2024 May 03, 2024	BUY	$0.7 - $1.75 $1,425 - $3,564	2,037 New	2,037 $3,000
Q4 2022 Jan 27, 2023	SELL	$1.05 - $2.53 $2,952 - $7,114	-2,812 Reduced 88.29%	373 $0
Q3 2022 Nov 08, 2022	BUY	$1.06 - $2.41 $2,557 - $5,815	2,413 Added 312.56%	3,185 $3,000
Q2 2022 Aug 10, 2022	SELL	$1.33 - $2.28 $472 - $809	-355 Reduced 31.5%	772 $1,000
Q1 2022 May 02, 2022	SELL	$1.73 - $4.06 $5,368 - $12,598	-3,103 Reduced 73.36%	1,127 $2,000
Q4 2021 Jan 25, 2022	BUY	$3.5 - $5.68 $80 - $130	23 Added 0.55%	4,230 $16,000
Q3 2021 Oct 28, 2021	BUY	$3.44 - $6.37 $13,701 - $25,371	3,983 Added 1778.13%	4,207 $22,000
Q2 2021 Jul 26, 2021	SELL	$3.86 - $5.78 $2,779 - $4,161	-720 Reduced 76.27%	224 $1,000
Q1 2021 Apr 30, 2021	BUY	$4.9 - $6.83 $3,528 - $4,917	720 Added 321.43%	944 $5,000
Q4 2020 Feb 11, 2021	BUY	$4.0 - $9.2 $896 - $2,060	224 New	224 $1,000
Q3 2020 Nov 03, 2020	SELL	$7.66 - $10.78 $2,857 - $4,020	-373 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$2.58 - $12.1 $962 - $4,513	373 New	373 $4,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$24.9 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$18.1 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$11.3 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$11.1 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$8.78 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $108M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account